MarketCap
Facebook
X
TelegramFluidigm Corporation Total Assets 2011-2026 | FLDM
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 325 M | 265 M | 304 M | 287 M | 306 M | 371 M | 408 M | 117 M | 114 M | 79.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 408 M | 79.3 M | 258 M |
Total Assets of other stocks in the Diagnostics research industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
77.2 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
16.1 M | $ 3.03 | -2.42 % | $ 98.3 K |  USA |
|
Akumin
AKU
|
1.77 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
17.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
30.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
94.3 M | $ 23.3 | -3.12 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
2.28 B | $ 34.75 | 2.9 % | $ 374 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
76.7 M | $ 1.34 | -8.84 % | $ 1.7 M | USA |
 |
Check-Cap Ltd.
CHEK
|
377 K | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
235 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
531 M | $ 39.22 | 0.15 % | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
62.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
95.3 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
77.5 B | $ 218.15 | -0.6 % | $ 159 B | USA |
 |
Exact Sciences Corporation
EXAS
|
5.93 B | $ 102.45 | 0.14 % | $ 19 B | USA |
 |
DermTech
DMTK
|
122 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
8.53 B | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
1.22 B | $ 26.05 | -0.72 % | $ 788 M | USA |
 |
Genetic Technologies Limited
GENE
|
20.8 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
975 M | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
1.49 B | $ 112.47 | 1.8 % | $ 13.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.18 B | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
6.26 B | $ 73.19 | -1.09 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
467 M | $ 20.35 | -2.18 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
245 M | $ 109.11 | -2.68 % | $ 4.3 B | USA |
 |
DarioHealth Corp.
DRIO
|
96.4 M | $ 10.14 | -1.55 % | $ 288 M | Israel |
 |
Enzo Biochem
ENZ
|
85.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
1.98 B | $ 66.29 | -0.59 % | $ 4.59 B | USA |
 |
Heska Corporation
HSKA
|
586 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
17.8 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
6.3 B | $ 144.63 | -3.38 % | $ 23 B | USA |
 |
QIAGEN N.V.
QGEN
|
5.69 B | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
26.9 B | $ 229.55 | -2.52 % | $ 41.6 B | USA |
 |
NeoGenomics
NEO
|
1.64 B | $ 11.92 | -3.87 % | $ 1.51 B | USA |
 |
Charles River Laboratories International
CRL
|
7.53 B | $ 209.14 | -1.23 % | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
2.1 B | $ 584.25 | -1.49 % | $ 18.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
16.2 B | $ 185.48 | 1.74 % | $ 20.6 B | USA |
|
Biodesix
BDSX
|
97.2 M | $ 9.45 | -2.17 % | $ 1.23 B | USA |
 |
Personalis
PSNL
|
270 M | $ 9.32 | -6.47 % | $ 552 M | USA |
 |
Motus GI Holdings
MOTS
|
7.22 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
18.1 M | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.4 B | $ 269.98 | 0.06 % | $ 22.7 B | USA |
 |
Mettler-Toledo International
MTD
|
3.24 B | $ 1 380.08 | -0.92 % | $ 29.3 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
16.9 B | $ 179.68 | -3.34 % | $ 14.8 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
3.29 B | $ 672.01 | -0.69 % | $ 55.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
29 B | $ 28.7 | -1.88 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
10.7 B | $ 132.44 | -0.6 % | $ 40.3 B | USA |
 |
Biomerica
BMRA
|
5.94 M | $ 2.35 | -1.67 % | $ 5.4 M | USA |